Since its introduction to the human population in December 2019, the coronavirus disease 2019 (COVID-19) pandemic has spread across the world with over 330,000 reported cases in 190 countries ([@r1]). While patients typically present with fever, shortness of breath, and cough, neurologic manifestations have been reported, although to a much lesser extent ([@r2]). We report the first presumptive case of COVID-19--associated acute necrotizing hemorrhagic encephalopathy, a rare encephalopathy that has been associated with other viral infections but has yet to be demonstrated as a result of COVID-19 infection.

A female airline worker in her late fifties presented with a 3-day history of cough, fever, and altered mental status. Initial laboratory work-up was negative for influenza, with the diagnosis of COVID-19 made by detection of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) viral nucleic acid in a nasopharyngeal swab specimen using the U.S. Centers for Disease Control and Prevention (CDC) 2019-Novel Coronavirus (2019-nCoV) Real-Time Reverse Transcriptase-Polymerase Chain Reaction assay. The assay was performed on a Roche thermocycler at our institution following "emergency use authorization" from the CDC. Cerebrospinal fluid (CSF) analysis was limited due to a traumatic lumbar puncture. However, CSF bacterial culture showed no growth after 3 days, and tests for herpes simplex virus 1 and 2, varicella zoster virus, and West Nile virus were negative. Testing for the presence of SARS-CoV-2 in the CSF was unable to be performed. Noncontrast head CT images demonstrated symmetric hypoattenuation within the bilateral medial thalami with a normal CT angiogram and CT venogram ([Fig 1](#fig1a){ref-type="fig"}). Images from brain MRI demonstrated hemorrhagic rim enhancing lesions within the bilateral thalami, medial temporal lobes, and subinsular regions ([Fig 2](#fig2a){ref-type="fig"}). The patient was started on intravenous immunoglobulin. High-dose steroids were not initiated due to concern for respiratory compromise.
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Acute necrotizing encephalopathy (ANE) is a rare complication of influenza and other viral infections and has been related to intracranial cytokine storms, which result in blood-brain-barrier breakdown, but without direct viral invasion or parainfectious demyelination ([@r3]). Accumulating evidence suggests that a subgroup of patients with severe COVID-19 might have a cytokine storm syndrome ([@r4]). While predominantly described in the pediatric population, ANE is known to occur in adults as well. The most characteristic imaging feature includes symmetric, multifocal lesions with invariable thalamic involvement ([@r5]). Other commonly involved locations include the brain stem, cerebral white matter, and cerebellum ([@r5]). Lesions appear hypoattenuating on CT images and MRI demonstrates T2 FLAIR hyperintense signal with internal hemorrhage. Postcontrast images may demonstrate a ring of contrast enhancement ([@r5]).

This is the first reported case of COVID-19--associated acute necrotizing hemorrhagic encephalopathy. As the number of patients with COVID-19 increases worldwide, clinicians and radiologists should be watching for this presentation among patients presenting with COVID-19 and altered mental status.
